These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 27289003)

  • 1. High homocysteine and low folate plasma concentrations are associated with cardiovascular events but not bleeding during warfarin treatment.
    Lind M; Jansson JH; Nilsson TK; Johansson L
    Clin Chem Lab Med; 2016 Dec; 54(12):1981-1986. PubMed ID: 27289003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-dimer predicts major bleeding, cardiovascular events and all-cause mortality during warfarin treatment.
    Lind M; Boman K; Johansson L; Nilsson TK; Järvholm LS; Jansson JH
    Clin Biochem; 2014 May; 47(7-8):570-3. PubMed ID: 24636802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function.
    Van Guelpen B; Hultdin J; Johansson I; Witthöft C; Weinehall L; Eliasson M; Hallmans G; Palmqvist R; Jansson JH; Winkvist A
    J Intern Med; 2009 Aug; 266(2):182-95. PubMed ID: 19298497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Serum Folate Levels With Cardiovascular Mortality Among Adults With Rheumatoid Arthritis.
    Sonawane K; Zhu Y; Chan W; Aguilar D; Deshmukh AA; Suarez-Almazor ME
    JAMA Netw Open; 2020 Feb; 3(2):e200100. PubMed ID: 32101310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum homocysteine and folate but not vitamin B12 are predictors of CHD mortality in older adults.
    Gopinath B; Flood VM; Rochtchina E; Thiagalingam A; Mitchell P
    Eur J Prev Cardiol; 2012 Dec; 19(6):1420-9. PubMed ID: 21960652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
    Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T
    JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients.
    Righetti M; Serbelloni P; Milani S; Ferrario G
    Blood Purif; 2006; 24(4):379-86. PubMed ID: 16755160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Willebrand factor predicts major bleeding and mortality during oral anticoagulant treatment.
    Lind M; Boman K; Johansson L; Nilsson TK; Järvholm LS; Jansson JH
    J Intern Med; 2012 Mar; 271(3):239-46. PubMed ID: 21707795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification.
    Selhub J; Jacques PF; Bostom AG; Wilson PW; Rosenberg IH
    Public Health Rev; 2000; 28(1-4):117-45. PubMed ID: 11411265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate, vitamin B12, and risk of ischemic and hemorrhagic stroke: a prospective, nested case-referent study of plasma concentrations and dietary intake.
    Van Guelpen B; Hultdin J; Johansson I; Stegmayr B; Hallmans G; Nilsson TK; Weinehall L; Witthöft C; Palmqvist R; Winkvist A
    Stroke; 2005 Jul; 36(7):1426-31. PubMed ID: 15933256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C and creatinine as markers of bleeding complications, cardiovascular events and mortality during oral anticoagulant treatment.
    Lind M; Jansson JH; Nilsson TK; Järvholm LS; Johansson L
    Thromb Res; 2013 Aug; 132(2):e77-82. PubMed ID: 23834818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.
    Ebbing M; Bleie Ø; Ueland PM; Nordrehaug JE; Nilsen DW; Vollset SE; Refsum H; Pedersen EK; Nygård O
    JAMA; 2008 Aug; 300(7):795-804. PubMed ID: 18714059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
    Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G
    Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine and vitamin B(12) concentrations and mortality rates in type 2 diabetes.
    Looker HC; Fagot-Campagna A; Gunter EW; Pfeiffer CM; Sievers ML; Bennett PH; Nelson RG; Hanson RL; Knowler WC
    Diabetes Metab Res Rev; 2007 Mar; 23(3):193-201. PubMed ID: 16845688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of folic acid fortification on plasma folate and total homocysteine concentrations.
    Jacques PF; Selhub J; Bostom AG; Wilson PW; Rosenberg IH
    N Engl J Med; 1999 May; 340(19):1449-54. PubMed ID: 10320382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-Dose folic acid supplementation decreases plasma homocysteine concentrations: a randomised trial.
    Brouwer IA; van Dusseldorp M; Thomas CMG ; Duran M; Hautvast JGAJ ; Eskes TKAB ; Steegers-Theunissen RP
    Indian Heart J; 2000; 52(7 Suppl):S53-58. PubMed ID: 11339442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels.
    Sofi F; Marcucci R; Bolli P; Giambene B; Sodi A; Fedi S; Menchini U; Gensini GF; Abbate R; Prisco D
    Atherosclerosis; 2008 May; 198(1):223-7. PubMed ID: 17945240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART).
    Held C; Sumner G; Sheridan P; McQueen M; Smith S; Dagenais G; Yusuf S; Lonn E
    Vasc Med; 2008 Nov; 13(4):245-53. PubMed ID: 18940900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.